| HOME >> MEDICINE >> TECHNOLOGY |
FIGURE 17 GLOBAL MARKET FOR LEUKOTRIENE MODIFIERS, THROUGH 2014 ($ MILLIONS) 96
Product Analysis 96
Singulair 96
TABLE 36 SINGULAIR ANALYSIS 97
BIOLOGICAL DRUGS 98
Overview 98
Market Revenues and Forecast 98
TABLE 37 GLOBAL MARKET FOR BIOLOGICAL DRUGS, THROUGH 2014 ($ MILLIONS) 99
FIGURE 18 GLOBAL MARKET FOR BIOLOGICAL DRUGS, 2007-2014 ($ MILLIONS) 99
Product Analysis 100
Xolair 100
TABLE 38 XOLAIR ANALYSIS 101
COMBINATION ICS/LABA DRUGS 101
OVERVIEW 101
TABLE 39 COMBINATION ICS/LABA INDUSTRY STRUCTURE, 2009 102
Market Revenues and Forecast 102
TABLE 40 MARKET SHARES OF LEADING COMPANIES SUPPLYING COMBINATION ICS/LABA, 2008 103
FIGURE 19 MARKET SHARES OF LEADING COMPANIES SUPPLYING COMBINATION ICS/LABA, 2008 (%) 103
Market Revenues and Forecast (Continued) 104
TABLE 41 GLOBAL MARKET FOR COMBINATION ICS/LABA DRUGS, THROUGH 2014 ($ MILLIONS) 105
FIGURE 20 GLOBAL MARKET FOR COMBINATION ICS/LABA DRUGS, 2007-2014 ($ MILLIONS) 105
Products Analysis 106
Advair/Seretide 106
TABLE 42 ADVAIR/SERETIDE ANALYSIS 107
Symbicort 107
Symbicort (Continued) 108
TABLE 43 SYMBICORT ANALYSIS 109
Chapter-7: MARKETS BY DISEASE
ASTHMA DRUGS MARKET 110
ASTHMA DRUGS 110
MARKET REVENUES 110
TABLE 44 GLOBAL MARKET FOR ASTHMA AND COPD PRESCRIPTION DRUGS BY DISEASE, 2008 ($ MILLIONS/%) 111
FIGURE 21 GLOBAL MARKET FOR ASTHMA AND COPD PRESCRIPTION DRUGS BY DISEASE, 2008 (%) 112
MARKET SHARES 112
TABLE 45 MARKET SHARES OF LEADING COMPANIES SUPPLYING THE ASTHMA DRUGS MARKET, 2008 113
FIGURE 22 MARKET SHARES OF LEADING COMPANIES SUPPL
'/>"/>
| SOURCE Reportlinker Copyright©2009 PR Newswire. All rights reserved |